Targeted use of prednisolone with the second IVIG dose for refractory Kawasaki disease.

about

Targeted use of prednisolone with the second IVIG dose for refractory Kawasaki disease.

Item

http://www.wikidata.org/entity/Q51391893

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh-hant

name

Targeted use of prednisolone with the second IVIG dose for refractory Kawasaki disease.

@en

Targeted use of prednisolone with the second IVIG dose for refractory Kawasaki disease.

@nl

type

Item

label

Targeted use of prednisolone with the second IVIG dose for refractory Kawasaki disease.

@en

Targeted use of prednisolone with the second IVIG dose for refractory Kawasaki disease.

@nl

prefLabel

Targeted use of prednisolone with the second IVIG dose for refractory Kawasaki disease.

@en

Targeted use of prednisolone with the second IVIG dose for refractory Kawasaki disease.

@nl

P1476

Targeted use of prednisolone with the second IVIG dose for refractory Kawasaki disease.

@en

P2093

Hideaki Morishita

http://www.w3.org/2001/XMLSchema#string

Hidemasa Sakai

http://www.w3.org/2001/XMLSchema#string

Ichiro Ohkawara

http://www.w3.org/2001/XMLSchema#string

Isao Asakura

http://www.w3.org/2001/XMLSchema#string

Masaki Shimomura

http://www.w3.org/2001/XMLSchema#string

Masashi Harazaki

http://www.w3.org/2001/XMLSchema#string

Mitsuaki Kimura

http://www.w3.org/2001/XMLSchema#string

Naoe Akiyama

http://www.w3.org/2001/XMLSchema#string

Satoru Iwashima

http://www.w3.org/2001/XMLSchema#string

Satoshi Tsurui

http://www.w3.org/2001/XMLSchema#string

P2860

Infliximab treatment for refractory Kawasaki syndrome

Re-treatment for immune globulin-resistant Kawasaki disease: a comparative study of additional immune globulin and steroid pulse therapy

Response of refractory Kawasaki disease to pulse steroid and cyclosporin A therapy

Predictors of coronary artery lesions after intravenous gamma-globulin treatment in Kawasaki disease.

Intravenous immunoglobulin plus corticosteroid to prevent coronary artery abnormalities in Kawasaki disease: a meta-analysis.

Evaluation of Kawasaki disease risk-scoring systems for intravenous immunoglobulin resistance

Descriptive epidemiology of Kawasaki disease in Japan, 2011-2012: from the results of the 22nd nationwide survey.

Infliximab for intensification of primary therapy for Kawasaki disease: a phase 3 randomised, double-blind, placebo-controlled trial.

Prediction of intravenous immunoglobulin unresponsiveness in patients with Kawasaki disease.

Importance of C-reactive protein level in predicting non-response to additional intravenous immunoglobulin treatment in children with Kawasaki disease: a retrospective study.

P304

397-403

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/PED.13190

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-10-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27743415

http://www.w3.org/2001/XMLSchema#string